News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
74,535 Results
Type
Article (1972)
Company Profile (4)
Press Release (72559)
Multimedia
Podcasts (1)
Webinars (1)
Section
Business (25422)
Career Advice (9)
Deals (4565)
Drug Development (8166)
FDA (1806)
Job Trends (805)
News (37100)
Policy (3561)
Tag
2027 BioCapital Standard (1)
Academia (105)
Accelerated approval (5)
ADA (2)
Allergies (27)
Alliances (8187)
ALS (23)
Alzheimer's disease (198)
Antibody-drug conjugate (ADC) (148)
Approvals (2000)
Artificial intelligence (45)
ASCO (37)
Autoimmune disease (45)
Automation (3)
Bankruptcy (10)
Best Places to Work (589)
BIO (12)
Biologics (10)
BIOSECURE Act (1)
Biosimilars (109)
BioSpace Insights (1)
Biotechnology (5)
Bispecific (10)
Bladder cancer (35)
Brain cancer (8)
Breast cancer (71)
Cancer (740)
Cardiovascular disease (33)
Career advice (9)
CAR-T (20)
CDC (2)
CDMO (14)
Celiac Disease (1)
Cell therapy (70)
Cervical cancer (5)
Clinical research (7889)
Collaboration (372)
Commercialization (18)
Compensation (28)
Complete response letters (8)
COVID-19 (207)
CRISPR (1)
C-suite (124)
Cystic fibrosis (9)
Data (1031)
Depression (18)
Dermatology (22)
Diabetes (56)
Diagnostics (665)
Digital health (8)
Drug discovery (49)
Drug pricing (1)
Duchenne muscular dystrophy (53)
Earnings (8388)
ESMO (50)
Events (7806)
Executive appointments (85)
Eye disease (2)
FDA (2399)
Fibrodysplasia Ossificans Progressiva (1)
Frontotemporal dementia (1)
Funding (176)
Gene editing (7)
Generative AI (1)
Gene therapy (47)
GLP-1 (89)
Government (246)
Grass and pollen (1)
Guidances (41)
Healthcare (1109)
Hematology (18)
HIV (7)
Huntington's disease (3)
Idiopathic pulmonary fibrosis (1)
IgA nephropathy (31)
Immunology and inflammation (9)
Immuno-oncology (15)
Indications (36)
Infectious disease (237)
Inflammatory bowel disease (27)
Inflation Reduction Act (1)
Influenza (15)
Intellectual property (46)
IPO (1650)
Job creations (241)
Job search strategy (9)
JPM (3)
Kidney cancer (2)
Kidney disease (14)
Layoffs (9)
Legal (953)
Licensing (35)
Liver cancer (23)
Longevity (3)
Lung cancer (143)
Lung diease (3)
Lymphoma (65)
Machine learning (2)
Manufacturing (166)
Marketing (10)
MASH (20)
Medical device (1181)
Medtech (1203)
Mergers & acquisitions (3142)
Metabolic disorders (137)
mRNA (11)
Multiple sclerosis (31)
NASH (1)
Neurodegenerative disease (40)
Neuropsychiatric disorders (7)
Neuroscience (390)
NextGen: Class of 2026 (223)
Non-profit (65)
Obesity (47)
Opinion (2)
Ovarian cancer (38)
Pain (24)
Pancreatic cancer (35)
Parkinson's disease (54)
Partnered (4)
Patents (82)
Patient recruitment (94)
Patient selection (20)
Peanut (2)
People (5270)
Peptides (2)
Pharmaceutical (2)
Pharmacy benefit managers (5)
Phase 1 (2124)
Phase 2 (3351)
Phase 3 (2988)
Pipeline (1680)
Policy (2)
Postmarket research (241)
Preclinical (720)
Press Release (2)
Prostate cancer (31)
Psychedelics (1)
Radiopharmaceuticals (31)
Rare diseases (105)
Real estate (613)
Regenerative medicine (7)
Regulatory (3164)
Reports (11)
Research institute (99)
Rett syndrome (2)
RNA editing (3)
RSV (3)
Schizophrenia (28)
Series A (39)
Series B (25)
Service/supplier (1)
Sickle cell disease (9)
Spinal muscular atrophy (5)
Sponsored (1)
Startups (433)
Stomach cancer (2)
Substance use disorders (2)
Supply chain (15)
Switzerland (8)
The Weekly (1)
Vaccines (52)
Venture capital (8)
Weight loss (23)
Women's health (10)
Date
Today (24)
Last 7 days (83)
Last 30 days (356)
Last 365 days (2943)
2026 (2629)
2025 (2692)
2024 (3278)
2023 (3843)
2022 (7036)
2021 (6404)
2020 (5877)
2019 (3869)
2018 (3019)
2017 (3563)
2016 (3171)
2015 (4029)
2014 (3020)
2013 (2600)
2012 (2775)
2011 (2902)
2010 (2663)
Location
Africa (89)
Alabama (5)
Arizona (15)
Arkansas (1)
Asia (22493)
Australia (2506)
California (957)
Canada (530)
China (611)
Colorado (6)
Connecticut (33)
Delaware (9)
Europe (13789)
Florida (101)
Georgia (18)
Hawaii (1)
Illinois (51)
India (71)
Indiana (38)
Japan (401)
Kansas (5)
Louisiana (2)
Maine (4)
Maryland (143)
Massachusetts (756)
Michigan (9)
Minnesota (42)
Missouri (3)
Nebraska (3)
Nevada (17)
New Hampshire (1)
New Jersey (597)
New York (313)
North Carolina (143)
Northern California (417)
Ohio (8)
Oregon (1)
Pennsylvania (182)
Puerto Rico (1)
Rhode Island (1)
South America (109)
South Carolina (1)
Southern California (470)
Tennessee (6)
Texas (74)
United States (3652)
Utah (48)
Vermont (1)
Virginia (74)
Washington D.C. (3)
Washington State (69)
Wisconsin (9)
Wyoming (1)
74,535 Results for "exscientia ltd".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Femcare Ltd Acquires Orion Medical Supplies Ltd in the UK
August 31, 2026
·
2 min read
Exscientia to Present at Upcoming Investor Conferences in June
Exscientia plc (Nasdaq: EXAI) today announced that members of Exscientia management will participate in the following upcoming investor conferences in June.
May 30, 2024
·
1 min read
Press Releases
Transpharmation Ltd. Announces Strategic Acquisition of OrganoTherapeutics SARL
October 28, 2026
·
5 min read
Business
Exscientia Announces Expansion of its Current Collaboration with Sanofi to Include Existing Exscientia Programme
Exscientia plc announced that Sanofi is adding a new discovery stage programme identified and initially advanced by Exscientia into the current collaboration.
December 21, 2023
·
3 min read
Press Releases
CELLYAN BIOTECHNOLOGY CO., LTD REGAINS COMPLIANCE WITH NASDAQ MINIMUM BID PRICE REQUIREMENT
November 16, 2026
·
2 min read
Press Releases
Alpha Pro Tech, Ltd. Announces Third Quarter 2026 Financial Results
November 10, 2026
·
13 min read
Press Releases
TME Pharma Signs Binding Exclusive Negotiation Agreement with Japanese TMS Co., Ltd.
October 29, 2026
·
7 min read
Press Releases
TempraMed Technologies Ltd. Announces Closing of Private Placement
October 1, 2026
·
5 min read
Press Releases
J-Star Holding Co., Ltd. Provides Update on Capital Structure Authorization and Strategic Execution Timeline
November 4, 2026
·
2 min read
Business
Exscientia to Report First Quarter 2024 Financial Results on May 21, 2024
Exscientia plc (Nasdaq: EXAI) will report financial results for the first quarter ended March 31, 2024, on Tuesday, May 21, 2024, before the open of U.S. markets.
May 14, 2024
·
1 min read
1 of 7,454
Next